Clinical trial
Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF…
NCT00381628 · University Hospitals Cleveland Medical Center, Other · Completed
Key facts
| NCT number | NCT00381628 |
|---|---|
| Title | Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations |
| Official title | Use of Nasal Epithelial Cells and Blood Lymphocytes to Identify Markers for Cystic Fibrosis and Cystic Fibrosis Pulmonary Exacerbations |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Cystic Fibrosis Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Cystic Fibrosis |
| Intervention type | Procedure |
| Interventions | epithelial cells and blood lymphocyte extraction |
| Enrollment | 59 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Sep 28, 2006 |
| Last update posted | Feb 15, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: